352 related articles for article (PubMed ID: 25906059)
1. Chemotherapy in glioma.
Taal W; Bromberg JE; van den Bent MJ
CNS Oncol; 2015; 4(3):179-92. PubMed ID: 25906059
[TBL] [Abstract][Full Text] [Related]
2. Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.
van den Bent MJ
Neuro Oncol; 2014 Dec; 16(12):1570-4. PubMed ID: 25355680
[TBL] [Abstract][Full Text] [Related]
3. Adults with newly diagnosed high-grade gliomas.
Croteau D; Mikkelsen T
Curr Treat Options Oncol; 2001 Dec; 2(6):507-15. PubMed ID: 12057096
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for diffuse low-grade gliomas in adults.
Ducray F
Rev Neurol (Paris); 2011 Oct; 167(10):673-9. PubMed ID: 21906770
[TBL] [Abstract][Full Text] [Related]
5. High-grade Gliomas.
Nayak L; Reardon DA
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1548-1563. PubMed ID: 29200110
[TBL] [Abstract][Full Text] [Related]
6. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
9. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for adults with malignant glioma: a systematic review.
Perry J; Laperriere N; Zuraw L; Chambers A; Spithoff K; Cairncross JG; ;
Can J Neurol Sci; 2007 Nov; 34(4):402-10. PubMed ID: 18062446
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
12. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
Narita Y
Prog Neurol Surg; 2018; 31():145-151. PubMed ID: 29393182
[TBL] [Abstract][Full Text] [Related]
14. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
16. [Chemo-radiotherapy for malignant brain tumors].
Kochi M; Ushio Y
Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeted therapies and chemotherapy in malignant gliomas.
Brandsma D; van den Bent MJ
Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
van den Bent MJ; Smits M; Kros JM; Chang SM
J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
[TBL] [Abstract][Full Text] [Related]
19. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
Jeremic B; Jovanovic D; Djuric LJ; Jevremovic S; Mijatovic LJ
J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
[TBL] [Abstract][Full Text] [Related]
20. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]